Expand CPIX Menu
CPIX MENU

CPIX Latest Press Releases

-- July 13, 2026 --

/C O R R E C T I O N -- Cumberland Pharmaceuticals Inc./ PRNewswire 11:21 AM
CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE PRNewswire 10:47 AM

-- July 1, 2026 --

Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex PRNewswire 9:01 AM

-- June 26, 2026 --

Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference PRNewswire 11:00 AM

-- June 22, 2026 --

RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement PRNewswire 4:10 PM

-- June 18, 2026 --

RedHill Biopharma Announces Up To $19.4 Million Private Placement PRNewswire 8:00 AM

-- June 9, 2026 --

RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation PRNewswire 7:00 AM

-- June 8, 2026 --

RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo PRNewswire 7:00 AM

-- June 2, 2026 --

Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis PRNewswire 9:05 AM
RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms PRNewswire 8:00 AM

-- May 28, 2026 --

CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV IN CHINA PRNewswire 9:05 AM

-- April 30, 2026 --

RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease PRNewswire 7:00 AM

-- April 28, 2026 --

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE PRNewswire 4:05 PM

-- April 27, 2026 --

RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights PRNewswire 8:00 AM

-- April 23, 2026 --

Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex PRNewswire 9:01 AM

-- April 22, 2026 --

RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026 PRNewswire 8:00 AM

-- April 16, 2026 --

CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLOR (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE PRNewswire 9:05 AM

-- March 17, 2026 --

Cumberland Pharmaceuticals Launches New Sancuso Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting PRNewswire 9:05 AM

-- March 4, 2026 --

H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight PRNewswire 5:46 PM

-- March 3, 2026 --

CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH PRNewswire 5:00 PM
Market Data Delayed 15 Minutes